TaLi Digital (ASX:TD1) - CEO, Dr Mary Beth Brinson
CEO, Dr Mary Beth Brinson
Source: Dr Mary-Beth Brinson/LinkedIn
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • TALi Digital (TD1) formally appoints Dr Mary-Beth Brinson as CEO, effective immediately
  • Dr Brinson is the current Chief Medical Officer and has been the interim CEO since April
  • The Board felt her broad experience and business capabilities, including a 16-year career at medical devices company Cochlear (COH), made her the right person for the role
  • The total remuneration package includes a $310,000 per annum salary, excluding superannuation
  • Shares in TALi Digital are up 16.7 per cent, trading at 0.7 cents as of 1:55 pm AEST

TALi Digital (TD1) has formally appointed Dr Mary-Beth Brinson as CEO, effective immediately.

Dr Brinson is the current Chief Medical Officer and has been the interim CEO since April.

The Board felt her broad experience and business capabilities, including a 16-year career at medical devices company Cochlear (COH), made her the right person for the role.

“I am very pleased to accept the role of CEO at TALi Health,” Dr Brinson commented.

“The opportunity to help children with chronic attention issues using digital therapeutics is an important one. I am looking forward to achieving this goal with TALi Health.”

A qualified audiologist, Dr Brinson was the former Vice President of Global Clinical Affairs at Cochlear and is an Adjunct Fellow at Macquarie University in Sydney.

She holds a Doctorate in Audiology from the University of Louisville in Kentucky, a Master of Business Administration from Rutgers University in New Jersey and a bachelor’s degree in Audiology and Speech Pathology from the University of Georgia in the US.

The total remuneration package includes a $310,000 per annum salary, excluding superannuation.

She is eligible for short-term and long-term incentives at the Board’s discretion upon achievement of mutually agreed key performance indicators and shareholder approval.

Both Dr Brinson and the company are required to provide four weeks’ notice of
resignation or termination respectively.

Shares in TALi Digital were up 16.7 per cent, trading at 0.7 cents as of 1:55 pm AEST.

TD1 by the numbers
More From The Market Online
Market Close Graphic

ASX Market Close: Another reversal as just-green Oz markets ignore US dive | Jan 3, 2024

The Aussie bourse has defied morning expectations for the second time in as many days, closing out all but flat with a 0.
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next